Upcoming educational webinar on genetic testing in cardiology
June 28th, 9:00AM PST, 6:00PM CET
Raising the bar: What to expect from cardiovascular genetic testing in 2018
The last decade has led cardiovascular (CV) genetic testing down a windy and bumpy road. Multiple efforts have been made over the years to streamline genetic testing in this and other areas: significantly improving testing and interpretation technology, standardizing variant classification, and shedding light on the increasingly recognized “genes of uncertain significance.” With so many laboratories to choose from, health care professionals should have high expectations of the CV genetics offering from these companies.
- Outline the important quality coverage metrics to consider when choosing a cardiac gene panel
- Review the existing limitations in the analysis of certain cardiac specific genes
- Demonstrate the steps taken to build a carefully curated, clinically relevant cardiac gene panel
The intent is to assist the provider in navigating their cardiovascular genetic testing options with the end goal of choosing a trustworthy test with the highest likelihood of yielding an informative result for their patient and family.
Dr. Tero-Pekka Alastalo, CMO and President at Blueprint Genetics, designs diagnostic panels and mutation databases and works with clinical evaluation of genetic data. Tero-Pekka has a MD-PhD degree, a PhD in molecular and cellular biology, and is specialized in pediatrics and pediatric cardiology. In 2007, he continued his research at Stanford University, School of Medicine. During this three year postdoctoral training, he focused on the molecular genetic mechanisms of cardiovascular diseases. He continued his cardiovascular research at the University of Helsinki as a principal investigator and the head of an academic research group.
Julie Hathaway, is a Clinical Liaison at Blueprint Genetics. She has over 6 years experience working in cardiac genetics; her past roles include both program coordinator and genetic counselor in a provincial multidisciplinary inherited arrhythmia program. Julie is an American and Canadian Board Certified Genetic counselor.